High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocol

Arnaud Thille; Grégoire Muller; Arnaud Gacouin; Rémi Coudroy; Alexandre Demoule; Romain Sonneville; François Beloncle; Christophe Girault; Laurence Dangers; Alexandre Lautrette; Séverin Cabasson; Anahita Rouzé; Emmanuel Vivier; Anthony Le Meur; Jean-Damien Ricard; Keyvan Razazi; Guillaume Barberet; Christine Lebert; Stephan Ehrmann; Walter Picard; Jeremy Bourenne; Gael Pradel; Pierre Bailly; Nicolas Terzi; Matthieu Buscot; Guillaume Lacave; Pierre-Eric Danin; Hodanou Nanadoumgar; Aude Gibelin; Lassane Zanre; Nicolas Deye; Stéphanie Ragot; Jean-Pierre Frat

doi:10.1136/bmjopen-2018-023772

Article dans une revue

High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocol

Arnaud Thille ^{1, *} Grégoire Muller ² Arnaud Gacouin ^{3, 4} Rémi Coudroy ⁵ Alexandre Demoule ⁶ Romain Sonneville ⁷ François Beloncle ⁸ Christophe Girault ⁹ Laurence Dangers ^{10, 6} Alexandre Lautrette ¹¹ Séverin Cabasson Anahita Rouzé ¹² Emmanuel Vivier ¹³ Anthony Le Meur Jean-Damien Ricard ¹⁴ Keyvan Razazi Guillaume Barberet Christine Lebert ¹⁵ Stephan Ehrmann ¹⁶ Walter Picard Jeremy Bourenne ¹⁷ Gael Pradel ¹⁸ Pierre Bailly ¹⁹ Nicolas Terzi ²⁰ Matthieu Buscot Guillaume Lacave Pierre-Eric Danin ²¹ Hodanou Nanadoumgar ^{5, 22, 23} Aude Gibelin ²⁴ Lassane Zanre Nicolas Deye ²⁵ Stéphanie Ragot ^{26, 27} Jean-Pierre Frat ²⁸

* Auteur correspondant

1 IMRB - Institut Mondor de recherche biomédicale

2 Réanimation Médicale [CHR d'Orléans]

3 CHU Pontchaillou [Rennes]

4 CIC - Centre d'Investigation Clinique [Rennes]

5 CHU Poitiers - Centre hospitalier universitaire de Poitiers

6 CHU Pitié-Salpêtrière [AP-HP]

7 Hôpital Bichat - Claude Bernard

8 MITOVASC - Physiopathologie Cardiovasculaire et Mitochondriale

9 CHU Rouen

10 Neurophysiologie Respiratoire Expérimentale et Clinique

11 Unité de soins intensifs [Clermont Ferrand]

12 CHRU Lille - Centre Hospitalier Régional Universitaire [Lille]

13 Centre hospitalier Saint Joseph - Saint Luc [Lyon]

14 EEM - Ecologie et Evolution des Microorganismes

15 Service de Réanimation Polyvalente

16 Pathologies Respiratoires : Protéolyse et Aérosolthérapie

17 Service d'anesthésie et de réanimation [Hôpital de la Timone - APHM]

18 CHU Nîmes - Centre Hospitalier Universitaire de Nîmes

19 LEPII - Laboratoire d'Economie de la Production et de l'Intégration Internationale

20 CHU Caen

21 Service de Réanimation médico-chirurgicale [Nice]

22 Modélisations pharmacocinétiques-pharmacodynamiques pour un meilleur usage des anti-infectieux

23 Université de Poitiers - Faculté de Médecine et de Pharmacie

24 CHU Tenon [APHP]

25 Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]

26 Pôle DUNE

27 CIC - Poitiers

28 Service de Réanimation Médicale (CHU Poitiers)

Abstract : Introduction - Recent practice guidelines suggest applying non-invasive ventilation (NIV) to prevent postextubation respiratory failure in patients at high risk of extubation failure in intensive care unit (ICU). However, such prophylactic NIV has been only a conditional recommendation given the low certainty of evidence. Likewise, high-flow nasal cannula (HFNC) oxygen therapy has been shown to reduce reintubation rates as compared with standard oxygen and to be as efficient as NIV in patients at high risk. Whereas HFNC may be considered as an optimal therapy during the postextubation period, HFNC associated with NIV could be an additional means of preventing postextubation respiratory failure. We are hypothesising that treatment associating NIV with HFNC between NIV sessions may be more effective than HFNC alone and may reduce the reintubation rate in patients at high risk. Methods and analysis - This study is an investigator-initiated, multicentre randomised controlled trial comparing HFNC alone or with NIV sessions during the postextubation period in patients at high risk of extubation failure in the ICU. Six hundred patients will be randomised with a 1:1 ratio in two groups according to the strategy of oxygenation after extubation. The primary outcome is the reintubation rate within the 7 days following planned extubation. Secondary outcomes include the number of patients who meet the criteria for moderate/severe respiratory failure, ICU length of stay and mortality up to day 90. Ethics and dissemination - The study has been approved by the ethics committee and patients will be included after informed consent. The results will be submitted for publication in peer-reviewed journals. Trial registration number - NCT03121482.

Keywords : adult intensive and critical care Clinical trials

Type de document :

Article dans une revue

Domaine :

Sciences du Vivant [q-bio]

Liste complète des métadonnées

https://hal.univ-angers.fr/hal-02616800
Contributeur : Okina Université d'Angers <>
Soumis le : dimanche 24 mai 2020 - 23:39:27
Dernière modification le : jeudi 25 février 2021 - 13:18:15

High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocol

Lien texte intégral

Identifiants

Collections

Citation

Exporter

Métriques

186

High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocol

Lien texte intégral

Identifiants

Collections

Citation

Exporter

Partager

Métriques

186